Amlodipine/candesartan cilexetil - Shin Poong Pharmaceuticals
Alternative Names: CANDEAMLO; CandeAmlo; Candersartan cilexetil/amlodipine - Shin Poong PharmaeuticalsLatest Information Update: 22 Feb 2022
At a glance
- Originator Shin Poong Pharmaceutical
- Class Antihypertensives; Benzimidazoles; Biphenyl compounds; Dihydropyridines; Heart failure therapies; Ischaemic heart disorder therapies; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 31 Dec 2016 Launched for Hypertension in South Korea (PO) (Shin Poong Pharmaceutical pipeline, February 2022)
- 31 Dec 2016 Registered for Hypertension in South Korea (PO) (Shin Poong Pharmaceutical pipeline, February 2022)